Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy

Clara Theunis(Janssen (Belgium)), Andreas Muhs(AC Immune (Switzerland)), María Pilar López-Deber(AC Immune (Switzerland)), Valérie Gafner(AC Immune (Switzerland)), Maria Pihlgren(World Trade Organization), Nathalie Chuard(AC Immune (Switzerland)), Oskar Adolfsson(AC Immune (Switzerland)), Dorin Mlaki Ndao(AC Immune (Switzerland)), Natàlia Crespo‐Biel(KU Leuven), David T. Hickman(AC Immune (Switzerland)), Herman Devijver(KU Leuven), Pedro Reis(AC Immune (Switzerland)), Fred Van Leuven(KU Leuven), Andrea Pfeifer(AC Immune (Switzerland)), Peter Borghgraef(Allen Institute for Brain Science)
PLoS ONE
August 19, 2013
Cited by 253


Related Papers